Chromosome aberration at
MYC locus is the most frequently reported genetic abnormality in advanced
human HCC [7]. Since c-Myc is a crucial regulator of cell cycle
progression, apoptosis and cellular transformation [10], drugs targeting
this gene may gain more efficient anticancer effect and improve the
treatment of HCC.